LOADING
Comparing AbbVie Inc (ABBV) and Merck & Company (MRK), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $355.4B | $276.4B |
| P/E Ratio | 84.8 | 15.4 |
| Forward P/E | 14.2 | 22.4 |
| PEG Ratio | 0.47 | 3.50 |
| EPS | $2.37 | $7.28 |
| Revenue Growth (YoY) | 10.0% | 5.0% |
| Profit Margin | 6.9% | 28.1% |
| Return on Equity | 62.3% | 36.9% |
| Dividend Yield | 3.32% | 2.83% |
| Beta | 0.36 | 0.28 |
| 52-Week High | $239.13 | $124.22 |
| 52-Week Low | $171.00 | $70.74 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.